8th August 2019
Nemera, the manufacturer of complex healthcare delivery devices, has completed the acquisition of Insight Product Development, a 100% healthcare focused design and innovation consulting firm based in Chicago, IL (USA).
Insight delivers innovation in both medical and drug delivery devices services spanning the full development life cycle from early user research and human factors through to verification and design transfer. For decades, Insight Product Development has helped clients discover, innovate and develop new product solutions through a user-centred design approach.
This acquisition strengthens our engagement to take patients’ needs into account at every stage of product development cycle and to guarantee the best match with their needs
Marc Hämel, CEO of Nemera
Hämel, Nemera CEO
This set of capabilities will perfectly complement Nemera’s well established design centre in La Verpillière (France). Located close to Nemera’s GMP manufacturing facility in Buffalo Grove, IL (USA), this strategic acquisition brings a strong development footprint in North America and significantly improves proximity to North America based customers.
The combination of both innovation organisations combines the strengths of Insight Product Development in front-end innovation, design research, human factors and design engineering with Nemera’s strong late-stage development, as well as clinical and commercial manufacturing capabilities. These newly enhanced capabilities enable Nemera to now offer complete end to end development services to all its customers globally and to collaborate with them earlier, supporting their complex drug delivery and medical device projects.
From today, Insight Product Development becomes an integral part of the newly branded Nemera’s Insight Innovation Center with offices in La Verpillière, France and Chicago, IL.
Nemera’s Insight Innovation Center will leverage a large cross-disciplinary team of 150 passionate and dedicated innovation experts to develop tailored solutions across multiple device platforms, reflecting Nemera’s vision to put patients first through user centred research and design.
“Insight’s expertise of understanding patient needs and translating that into impactful product designs aligns perfectly with our purpose to ‘put patients first’.” – commented Marc Hämel, Nemera’s CEO – “This acquisition strengthens our engagement to take patients’ needs into account at every stage of product development cycle and to guarantee the best match with their needs”.
“Insight is very honoured to be joining Nemera, a world class leader in the innovation and manufacture of so many impressive drug delivery systems.” – explained Craig Scherer, Insight Product Development’s Co-founder – “Bolstering Nemera’s front end offerings in user research and design, Insight is very pleased to help Nemera provide exceptional capabilities to their clients from innovation through industrialisation.”
Montagu first partnered with Nemera in its 2014 carve-out from Rexam. Montagu reinvested in the business in 2019 supporting its ambitious organic and acquisitive growth plans.
20th January 2021